HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. (Q42995407)
Jump to navigation
Jump to search
scientific article published on 8 March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. |
scientific article published on 8 March 2010 |
Statements
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy (English)
Vincenzo Pitini
Giuseppe Sturniolo
Carmela Arrigo
Silvana Leonardi
Salvatrice Pino